McKinsey Global Institute projected that broad GLP-1 adoption for eligible obese adults in high-income countries could generate USD 1.8 trillion in cumulative healthcare savings by 2040 through reduced cardiovascular hospitalizations, diabetes complication avoidance, and musculoskeletal disease prevention
Semaglutide for weight loss is not recommended for patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or certain other medical conditions
Contact your healthcare provider immediately if you experience: Severe, persistent diarrhea preventing adequate hydration Clinical signs of dehydration (dizziness, dry mouth, dark urine, orthostatic symptoms) Blood in stool or severe abdominal pain Fever accompanying diarrhea Inability to maintain fluid intake due to concurrent vomiting Clinical reports have documented cases of acute kidney injury from severe volume depletion due to excessive diarrhea on GLP-1 therapy
When youre hot, your body increases blood flow to the skin to release heat
A recent study in Denmark showed that GLP-1 agonists may improve the disease course of IBD